Anxiety and Related Sleep Disorders - Saudi Arabia

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$54.60m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.10%, resulting in a market volume of US$54.89m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$23.77 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Saudi Arabia is experiencing significant growth due to increasing customer preferences for natural and holistic remedies, as well as the rising awareness and diagnosis of these conditions. Customer preferences in the Anxiety and Related Sleep Disorders market in Saudi Arabia are shifting towards natural and holistic remedies. Consumers are becoming more conscious of the potential side effects and long-term health risks associated with pharmaceutical medications, leading them to seek alternative treatment options. This has resulted in a growing demand for herbal supplements, essential oils, and relaxation techniques such as meditation and yoga. Additionally, there is a preference for products that are free from artificial ingredients and chemicals, aligning with the overall trend towards clean and organic living.The market is also driven by the increasing awareness and diagnosis of anxiety and related sleep disorders in Saudi Arabia. As mental health awareness grows worldwide, Saudi Arabia is no exception. There is a greater recognition of the impact of stress, anxiety, and sleep disorders on overall well-being, leading more individuals to seek professional help and treatment. This has resulted in an increased demand for medications, therapy sessions, and sleep aids.In addition to customer preferences, there are several local special circumstances that contribute to the development of the Anxiety and Related Sleep Disorders market in Saudi Arabia. The culture in Saudi Arabia places a strong emphasis on family and community, which can lead to higher levels of stress and pressure to meet societal expectations. This, combined with the fast-paced modern lifestyle and the prevalence of technology, has resulted in a higher incidence of anxiety and sleep disorders among the population.Underlying macroeconomic factors also play a role in the growth of the market. Saudi Arabia has a strong healthcare system and a high level of disposable income, allowing individuals to afford the necessary treatments and therapies. Additionally, the government has recognized the importance of mental health and has implemented initiatives to improve access to mental health services and raise awareness about these conditions.In conclusion, the Anxiety and Related Sleep Disorders market in Saudi Arabia is developing due to increasing customer preferences for natural and holistic remedies, rising awareness and diagnosis of these conditions, local special circumstances, and underlying macroeconomic factors. As the market continues to grow, there will likely be a greater focus on innovative and personalized treatment options to cater to the specific needs of individuals in Saudi Arabia.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.